SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001664710-24-000055
Filing Date
2024-06-17
Accepted
2024-06-17 06:07:19
Documents
49
Period of Report
2024-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kros-20240617.htm   iXBRL 8-K 38718
2 EX-99.1 exhibit991eha2024.htm EX-99.1 32281
3 EX-99.2 a62024corporateupdate.htm EX-99.2 48560
7 a62024corporateupdate001.jpg GRAPHIC 77996
8 a62024corporateupdate002.jpg GRAPHIC 255142
9 a62024corporateupdate003.jpg GRAPHIC 146579
10 a62024corporateupdate004.jpg GRAPHIC 61387
11 a62024corporateupdate005.jpg GRAPHIC 146584
12 a62024corporateupdate006.jpg GRAPHIC 159259
13 a62024corporateupdate007.jpg GRAPHIC 85796
14 a62024corporateupdate008.jpg GRAPHIC 104858
15 a62024corporateupdate009.jpg GRAPHIC 178677
16 a62024corporateupdate010.jpg GRAPHIC 103185
17 a62024corporateupdate011.jpg GRAPHIC 148125
18 a62024corporateupdate012.jpg GRAPHIC 174018
19 a62024corporateupdate013.jpg GRAPHIC 112715
20 a62024corporateupdate014.jpg GRAPHIC 117466
21 a62024corporateupdate015.jpg GRAPHIC 162266
22 a62024corporateupdate016.jpg GRAPHIC 152181
23 a62024corporateupdate017.jpg GRAPHIC 143302
24 a62024corporateupdate018.jpg GRAPHIC 94053
25 a62024corporateupdate019.jpg GRAPHIC 111353
26 a62024corporateupdate020.jpg GRAPHIC 119660
27 a62024corporateupdate021.jpg GRAPHIC 110982
28 a62024corporateupdate022.jpg GRAPHIC 132190
29 a62024corporateupdate023.jpg GRAPHIC 173227
30 a62024corporateupdate024.jpg GRAPHIC 175274
31 a62024corporateupdate025.jpg GRAPHIC 170357
32 a62024corporateupdate026.jpg GRAPHIC 160906
33 a62024corporateupdate027.jpg GRAPHIC 140756
34 a62024corporateupdate028.jpg GRAPHIC 101916
35 a62024corporateupdate029.jpg GRAPHIC 118410
36 a62024corporateupdate030.jpg GRAPHIC 80535
37 a62024corporateupdate031.jpg GRAPHIC 94072
38 a62024corporateupdate032.jpg GRAPHIC 119360
39 a62024corporateupdate033.jpg GRAPHIC 54057
40 a62024corporateupdate034.jpg GRAPHIC 84216
  Complete submission text file 0001664710-24-000055.txt   6299137

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20240617.xsd EX-101.SCH 1901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20240617_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20240617_pre.xml EX-101.PRE 13046
52 EXTRACTED XBRL INSTANCE DOCUMENT kros-20240617_htm.xml XML 2823
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 241046881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)